This inventor holds 4 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: H&a Pharmachem Co., Ltd. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Innovator Spotlight: Yu Jin Kang
Introduction
Yu Jin Kang is a notable inventor based in Gyeonggi-do, South Korea. With a remarkable contribution to the field of pharmaceuticals, he holds a total of two patents that underscore his innovative approach to drug delivery systems.
Latest Patents
His latest patents include:
1. **Transdermal Delivery Complex Using Metal-Organic Framework and Nanocellulose**
This invention pertains to a transdermal delivery complex utilizing a metal-organic framework (MOF) combined with nanocellulose. The invention not only provides an innovative delivery method but also encompasses a cosmetic composition that incorporates this transdermal delivery complex, along with a method for its preparation.
2. **Cochleates Using Phosphatidylserine/Anionic Surfactant/Calcium Chloride**
This patent addresses cochleates that utilize phosphatidylserine, an anionic surfactant, and calcium chloride. It specifically focuses on the formulation of cochleates that include an active ingredient and water, aiming to improve the effectiveness of drug delivery.
Career Highlights
Yu Jin Kang works at H&A Pharmachem Co., Ltd., where he has made significant contributions that enhance pharmaceutical treatments. His role at the company highlights his dedication to advancing technology in the healthcare sector.
Collaborations
Kang collaborates with talented individuals such as Hong Geun Ji and Young Ah Park, who contribute to the collective knowledge and skills within the team, fostering an environment of innovation.
Conclusion
In conclusion, Yu Jin Kang embodies the spirit of innovation in the pharmaceutical industry through his inventions and collaborative efforts at H&A Pharmachem Co., Ltd. His work on transdermal delivery systems and cochleates stands as a testament to his commitment to enhancing drug delivery methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile